Mediclinic International Future Growth
Future criteria checks 2/6
Mediclinic International is forecast to grow earnings and revenue by 10.7% and 3.6% per annum respectively. EPS is expected to grow by 12.2% per annum. Return on equity is forecast to be 6.6% in 3 years.
Key information
10.7%
Earnings growth rate
12.2%
EPS growth rate
| Healthcare earnings growth | 20.9% |
| Revenue growth rate | 3.6% |
| Future return on equity | 6.6% |
| Analyst coverage | Good |
| Last updated | 30 May 2023 |
Recent future growth updates
Recent updates
Here's Why We Think Mediclinic International (LON:MDC) Might Deserve Your Attention Today
Jul 26
Estimating The Intrinsic Value Of Mediclinic International plc (LON:MDC)
Jul 12Here's Why Mediclinic International (LON:MDC) Can Manage Its Debt Responsibly
Jun 28Are Investors Undervaluing Mediclinic International plc (LON:MDC) By 50%?
Apr 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Mar 09Mediclinic International (LON:MDC) Takes On Some Risk With Its Use Of Debt
Nov 20Is There An Opportunity With Mediclinic International plc's (LON:MDC) 25% Undervaluation?
Sep 08Is Mediclinic International (LON:MDC) Using Too Much Debt?
Jun 21Does This Valuation Of Mediclinic International plc (LON:MDC) Imply Investors Are Overpaying?
May 26If You Had Bought Mediclinic International's (LON:MDC) Shares Five Years Ago You Would Be Down 63%
Mar 17What Kind Of Shareholders Hold The Majority In Mediclinic International plc's (LON:MDC) Shares?
Feb 26Mediclinic International plc (LON:MDC) Could Be Less Than A Year Away From Profitability
Feb 11Have Mediclinic International plc (LON:MDC) Insiders Been Selling Their Stock?
Jan 27
Estimating The Fair Value Of Mediclinic International plc (LON:MDC)
Jan 18These 4 Measures Indicate That Mediclinic International (LON:MDC) Is Using Debt Extensively
Jan 01A Look At Mediclinic International's (LON:MDC) Share Price Returns
Dec 17Our View On Mediclinic International's (LON:MDC) CEO Pay
Dec 02Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2026 | 3,888 | 271 | N/A | N/A | 1 |
| 3/31/2025 | 3,684 | 255 | 330 | 551 | 6 |
| 3/31/2024 | 3,564 | 237 | 309 | 525 | 6 |
| 3/31/2023 | 3,441 | 212 | 183 | 422 | 6 |
| 9/30/2022 | 3,383 | 169 | 283 | 470 | N/A |
| 6/30/2022 | 3,308 | 160 | 329 | 512 | N/A |
| 3/31/2022 | 3,233 | 151 | 375 | 554 | N/A |
| 12/31/2021 | 3,199 | 135 | 321 | 483 | N/A |
| 9/30/2021 | 3,165 | 118 | 266 | 412 | N/A |
| 6/30/2021 | 3,080 | 93 | 183 | 324 | N/A |
| 3/31/2021 | 2,995 | 68 | 99 | 235 | N/A |
| 12/31/2020 | 2,987 | -173 | N/A | N/A | N/A |
| 9/30/2020 | 2,979 | -414 | 133 | 306 | N/A |
| 6/30/2020 | 3,031 | -367 | 203 | 381 | N/A |
| 3/31/2020 | 3,083 | -320 | 273 | 456 | N/A |
| 12/31/2019 | 3,070 | -97 | N/A | N/A | N/A |
| 9/30/2019 | 3,057 | 126 | 246 | 443 | N/A |
| 6/30/2019 | 2,995 | -12 | 175 | 394 | N/A |
| 3/31/2019 | 2,932 | -151 | 104 | 344 | N/A |
| 12/31/2018 | 2,897 | -380 | N/A | N/A | N/A |
| 9/30/2018 | 2,861 | -610 | 23 | 277 | N/A |
| 6/30/2018 | 2,869 | -551 | 57 | 311 | N/A |
| 3/31/2018 | 2,876 | -492 | 91 | 345 | N/A |
| 12/31/2017 | 2,874 | -211 | N/A | N/A | N/A |
| 9/30/2017 | 2,871 | 69 | 97 | 350 | N/A |
| 6/30/2017 | 2,810 | 149 | 121 | 364 | N/A |
| 3/31/2017 | 2,749 | 229 | 145 | 377 | N/A |
| 12/31/2016 | 2,565 | 210 | 155 | 375 | N/A |
| 9/30/2016 | 2,380 | 191 | 165 | 373 | N/A |
| 6/30/2016 | 2,244 | 184 | N/A | 347 | N/A |
| 3/31/2016 | 2,107 | 177 | N/A | 320 | N/A |
| 12/31/2015 | 2,080 | 211 | N/A | 314 | N/A |
| 9/30/2015 | 2,183 | 257 | N/A | 330 | N/A |
| 6/30/2015 | 2,042 | 245 | N/A | 327 | N/A |
| 3/31/2015 | 1,977 | 241 | N/A | 337 | N/A |
| 12/31/2014 | 1,901 | 221 | N/A | 312 | N/A |
| 9/30/2014 | 1,810 | 199 | N/A | 284 | N/A |
| 6/30/2014 | 1,751 | 193 | N/A | 270 | N/A |
| 3/31/2014 | 1,738 | 193 | N/A | 263 | N/A |
| 12/31/2013 | 1,652 | 82 | N/A | 253 | N/A |
| 9/30/2013 | 1,653 | -33 | N/A | 257 | N/A |
| 6/30/2013 | 1,701 | -55 | N/A | 256 | N/A |
| 3/31/2013 | 1,742 | -79 | N/A | 253 | N/A |
| 12/31/2012 | 1,729 | 19 | N/A | 232 | N/A |
| 9/30/2012 | 1,730 | 118 | N/A | 213 | N/A |
| 6/30/2012 | 1,759 | 109 | N/A | 198 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MDC's forecast earnings growth (10.7% per year) is above the savings rate (1.2%).
Earnings vs Market: MDC's earnings (10.7% per year) are forecast to grow faster than the UK market (10.4% per year).
High Growth Earnings: MDC's earnings are forecast to grow, but not significantly.
Revenue vs Market: MDC's revenue (3.6% per year) is forecast to grow slower than the UK market (4% per year).
High Growth Revenue: MDC's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MDC's Return on Equity is forecast to be low in 3 years time (6.6%).